Zobrazeno 1 - 10
of 41
pro vyhledávání: '"David A. Vorchheimer"'
Autor:
Adarsh Katamreddy, Alexander M. Ye, David A. Vorchheimer, Isaac Hardoon, Robert T. Faillace, Cynthia C. Taub
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 39:1364-1370
Objective: We aim to explore patterns of inpatient code status during the COVID-19 pandemic compared with a similar timeframe the previous year, as well as utilization of palliative care services. Methods: This is a retrospective cohort study using d
Autor:
Harsh Jain, Jose Nunez, Hirva Vyas, Clark Yarber, Jay Chudow, Leandro Slipczuk, David A. Vorchheimer
Publikováno v:
Journal of the American College of Cardiology. 81:3728
Publikováno v:
Journal of the American College of Cardiology. 81:25
Autor:
Waqas Hanif, Ythan Goldberg, Cynthia C Taub, David A Vorchheimer, Leandro Slipczuk, Edwin Ho, Carlos Rodriguez, Muhammad Farooq, Mario J Garcia, Lili Zhang
Publikováno v:
Circulation. 144
Introduction: Left ventricular (LV) global longitudinal strain (GLS) is a robust LV systolic function measure used to detect subtle chemotherapy cardiotoxicity. However, inter-reader and inter-vendor variabilities compromise the clinical value of lon
Autor:
Christopher M. O'Connor, Tom W. Meade, Richard C. Becker, Peter B. Berger, Gordon H. Guyatt, Daniel B. Mark, Michael D. Ezekowitz, David A. Vorchheimer, Robert A. Harrington
Publikováno v:
Chest. 133:776S-814S
The following chapter devoted to antithrombotic therapy for chronic coronary artery disease (CAD) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Autor:
David A. Vorchheimer, Ethan A. Halm, Daichi Shimbo, Nina Rieckmann, Donald C. Haas, Ian M. Kronish, Karina W. Davidson
Publikováno v:
Journal of General Internal Medicine. 21:1178-1183
BACKGROUND: The persistence of depressive symptoms after hospitalization is a strong risk factor for mortality after acute coronary syndromes (ACS). Poor adherence to secondary prevention behaviors may be a mediator of the relationship between depres
Publikováno v:
Mayo Clinic Proceedings. 81:59-68
Atherosclerosis is a diffuse, systemic disease that affects the coronary, cerebral, and peripheral arterial trees. Disruption of atherosclerotic plaques leads to thrombus formation and arterial occlusion. This unpredictable and potentially life-threa
Autor:
Michael D. Ezekowitz, Tom W. Meade, Robert A. Harrington, David A. Vorchheimer, Richard C. Becker, Gordon H. Guyatt, Christopher M. O'Connor
Publikováno v:
Chest. 126:513S-548S
This chapter about antithrombotic therapy for coronary artery disease (CAD) is part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefit
Autor:
David A. Vorchheimer, David J. Harnick
Publikováno v:
Current Cardiology Reports. 3:355-361
Treatment of patients with acute coronary syndromes (ACS) incorporates several approaches to reverse or mitigate the thrombus, which invariably is at the center of the pathophysiologic process of ACS. Pharmacologic and mechanical strategies are desig
Autor:
Chiara Giannarelli, David A. Vorchheimer, Carlos G. Santos-Gallego, Joseph A. Jakubowski, Juan F. Viles-Gonzalez, Samantha Sartori, Valentin Fuster, D. S. Small, Mohammad Urooj Zafar, Sammy Elmariah, Juan J. Badimon
Publikováno v:
Journal of thrombosis and haemostasis : JTH, vol 11, iss 1
Summary. Background: Hemostatic benefits of platelet transfusions in thienopyridine-treated acute coronary syndrome (ACS) patients may be compromised by residual metabolite in circulation.Objectives: To estimate the earliest time after a prasugrel lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8599b9dcbce5340a3d8bf94c67bb028
https://escholarship.org/uc/item/2fc0n30n
https://escholarship.org/uc/item/2fc0n30n